Impact of Therapeutic Interventions on Fear of Progression in Patients with Endometriosis

article OA: gold CC0
AI-generated summary by claude@2026-06, 2026-06-07

This study found that exclusive hormonal treatment was associated with higher fear of progression compared to surgical interventions in endometriosis patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background/Objectives: Endometriosis is a chronic disease associated with pain, infertility, and increased risk of mental disorders (anxiety, depression). One of these manifestations is the fear of progression, recently documented in patients with endometriosis, which can affect their quality of life. Our study aims to evaluate the relationship between the fear of progression and the type of treatment in endometriosis. Methods: We conducted a prospective survey of 298 patients with endometriosis, divided into four treatment groups (hormonal therapy without or with surgical indication, surgical intervention, phytotherapy). Fear of progression (FoP) was evaluated through the Fear of Progression Questionnaire—Short Form (FoP-Q-SF). Scores were compared between groups using the Kruskal–Wallis test with Dunn’s post hoc analysis and adjusted for age (ANCOVA). Results: FoP was generally high. Significant differences between groups were observed (p = 0.021), with the highest FoP-Q-SF scores being in patients undergoing exclusive hormonal treatment, higher than in the surgical groups (p < 0.01). Younger age correlated with increased fear (p < 0.01). Conclusions: Treatment type influences anxiety regarding disease progression. Exclusive hormonal therapy was associated with the greatest fear of progression, while the differences observed between hormonal therapy with surgical indication and primary surgical treatment may partly be due to methodological or informational factors rather than purely clinical differences. A multidisciplinary approach, including psychological support, is essential to alleviate patient fears and improve their quality of life.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-05-29T00:31:22.949896+00:00
License: CC0 · commercial use OK